CMChristine Mrakotsky

Christine Mrakotsky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christine Mrakotsky has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Deborah Waber

    Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

    4 shared publications
  • Richard Grand

    Division of Gastroenterology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

    4 shared publications
  • Athos Bousvaros

    Center for Inflammatory Bowel Disease, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

    3 shared publications
  • Deborah P. Waber

    Department of Psychiatry, Boston Children’s Hospital/Harvard Medical School, Boston, MA, USA

    3 shared publications
  • Christine K. Fox

    Department of Neurology and Weill Institute for Neuroscience University of California San Francisco San Francisco California USA

    2 shared publications
  • Christopher G. Watson

    Graduate Program for Neuroscience, Boston University, Boston, MA; Department of Neurology, Boston Children's Hospital, Boston, MA

    2 shared publications

Latest Publications

  • Open Access

    Pediatric Intracerebral Hemorrhage Management—Consensus Statement of the International Pediatric Stroke Organization—Part 1: Acute Phase and Workup

    by Grégoire Boulouis, Christine K. Fox, Michaela Waak, Peter B. Sporns, Janette A. Mailo, Lauren A. Beslow, Max Wintermark, Melissa G. Chung, Dana B. Harrar, Arastoo Vossough, et al.

    Pediatric intracerebral hemorrhage (pICH) is a rare but serious neurologic emergency associated with significant morbidity. Although pICH accounts for nearly half of all pediatric strokes, it remains understudied, and dedicated evidence‐based management guidelines are lacking. To address this gap, the International Pediatric Stroke Organization convened a multidisciplinary international working group in 2020 to develop a comprehensive, consensus‐based framework for the acute evaluation and management of pICH in children aged 28 days to 18 years. The working group included child neurologists, neurointensivists, neurosurgeons, neuroradiologists, and neurointerventionalists. Subgroups conducted systematic literature reviews and formulated key clinical questions. A modified Delphi process was used to derive consensus statements across 6 domains: prehospital and emergency care, diagnostic imaging and workup, neurocritical care and medical management, neurosurgical and neurointerventional approaches, and identification of knowledge gaps. Through rounds of structured review and voting, 21 consensus statements were developed and approved. The process was endorsed by multiple professional societies. This represents the first international, multidisciplinary, multisociety consensus statement focused on the acute management of pICH in children. It provides structured, expert‐driven guidance to inform clinical decision‐making, reduce practice variability, and highlight areas for future research. These consensus statements aim to support clinicians worldwide in improving outcomes for children with pICH.


  • Open Access

    Pediatric Intracerebral Hemorrhage Management—Consensus Statement of the International Pediatric Stroke Organization—Part 2: Outcomes, Rehabilitation, and Transition to Adulthood

    by Christine Mrakotsky, Janette A. Mailo, Mathilde Chevignard, Nomazulu Dlamini, Christine K. Fox, Heather J. Fullerton, Laura L. Lehman, Grégoire Boulouis, Michaela Waak

    Pediatric hemorrhagic stroke can lead to significant neurologic, cognitive, and behavioral morbidities that often emerge over time and can impede long‐term academic, vocational, and socioemotional function. While many of the existing data stem from studies in arterial ischemic stroke, functional outcomes in hemorrhagic stroke, and particularly pediatric intracerebral hemorrhage, remain largely understudied. Extrapolating findings from ischemic stroke can be challenging, as there are notable differences in care and potentially in outcomes for hemorrhagic stroke. The primary goal of this consensus statement by a multidisciplinary group of stroke experts is to provide a review of the current literature on neurologic, cognitive, behavioral, and socioemotional outcomes after hemorrhagic stroke. Neurologically, children with pediatric intracerebral hemorrhage often experience motor deficits, including hemiparesis and coordination issues, as well as cognitive impairments affecting attention, memory, and executive function. Behavioral and emotional problems, such as depression, and social difficulties can also occur. Data on academic attainment are also presented, along with considerations regarding long‐term outcomes and the transition to adulthood. We further examine a variety of key determinants predicting outcomes, including medical, demographic, familial, and socioeconomic factors, as well as current research on rehabilitation, with an emphasis on gold‐standard guidelines for clinical interventions. Given the complexity of outcome measurement in pediatric hemorrhagic stroke and the lack of uniform tools for assessing outcomes across diverse populations, we propose guiding principles for outcome measurement, along with examples of domain‐specific tools. Finally, we discuss the limitations of the current literature and outline goals for future clinical practice and research.


  • Open Access

    The eTHINK Study: Cognitive and Behavioral Outcomes in Children with Hemophilia

    by Christine Mrakotsky, Karin S. Walsh, Cathy Buranahirun Burns, Stacy E. Croteau, Anja Markert, Milan Geybels, Cara Hannemann, Madhvi Rajpurkar, Kevin A. Shapiro, Greta N. Wilkening, et al.


  • Recent Advances in Neuropsychological Outcomes and Intervention in Pediatric Stroke

    by Lauren S. Krivitzky, Robyn Westmacott, Richard Boada, Leigh Sepeta, Lauren Reppert, Christine Mrakotsky

    Over the past 15 years, there have been significant advances in the treatment of acute and chronic medical consequences of stroke in childhood. Given high rates of survival in pediatric stroke, practitioners are tasked with treating the ongoing motor and neuropsychological sequelae in patients over the course of their development. This article provides a review of the current literature on neuropsychological outcomes in pediatric stroke, including intelligence, academics, language, visual-spatial skills, attention, executive functions, memory, and psychosocial function. Recent developments in functional neuroimaging are discussed, with a particular focus on language outcomes. We further review the current research on cognitive and behavioral rehabilitation and introduce intervention models in pediatric stroke. In the final section, we discuss future directions for clinical practice and research in pediatric stroke.


  • Rehabilitation in Pediatric Stroke: Cognition and Behavior

    by Christine Mrakotsky, Tricia S. Williams, Kevin A. Shapiro, Robyn Westmacott


  • Functional abdominal pain symptom severity: Associations between cognition and emotion in a pediatric sample

    by Donald J. Bearden, Deborah P. Waber, Jane E. Schreiber, Christine Mrakotsky

    Functional abdominal pain (FAP) is a common physical complaint in children and adolescents. Prior research has documented associations between FAP symptoms and mood, especially internalizing behaviors. Limited research is available examining the association between symptom burden and cognitive function in this pediatric population. This study explored associations between FAP symptoms, internalizing behaviors, and cognitive and school function in children and adolescents. Twenty-seven participants (mean age = 12.6 years, range 8.8–16.5; 33% male) diagnosed with FAP completed assessments of cognitive, emotional, and behavioral function, as well as FAP symptom severity. Mean performances on cognitive tests were within age-expected ranges. Within this context, however, higher overall burden of FAP symptoms was associated with slower processing speed, more self-reported metacognitive problems and internalizing behaviors, and more school absences. Cognitive function was systematically associated with internalizing behaviors but not physical symptoms. Overall, findings revealed that FAP may be associated with cognitive inefficiencies in addition to internalizing problems. Cognitive symptoms may be linked to internalizing behaviors associated with FAP.


  • Open Access

    Chronic Inflammation and Its Association With Neurobehavioral Functions in Pediatric Crohnʼs Disease

    by Christine Mrakotsky, Kristin Maletsky, Jonathan Girard, Deborah Waber, Athos Bousvaros, Richard Grand

    Pediatric Crohn's disease (CD) is associated with high circulating concentrations of pro-inflammatory cytokines (IL-6, TNF-α) and acute phase proteins (CRP). These proteins can cross the blood-brain-barrier. For example, IL-6 is expressed in the hippocampus, hypothalamus and cortex, TNF-α in microglia. Thus, excess cytokines have the potential to disrupt brain systems critical for memory, executive functions and mood. Children with CD therefore may be at particular risk for cognitive and emotional problems based on not only short and long-term medication regimens, but their underlying disease itself. Our earlier reports of behavioral impact of inflammation have been confounded by the fact that patients were concurrently treated with corticosteroids, which can cause similar behavioral and CNS side-effects. We here investigate the effects of inflammation on memory and executive functions independent of steroids. Behavioral and cytokine data from an ongoing NIH study were available on 61 children with CD age 8-16 years who have completed the study thus far. Patients were assessed at one time-point of a longitudinal design, when all were off steroids for at least 4-6 months. Standardized measures of memory, executive functions, IQ, mood, sleep, and pain severity were administered. Questionnaires included the Behavior Rating of Executive Functions (BRIEF), Child Behavior Checklist (CBCL), Youth Self Report (YSR), and Children's Depression Inventory (CDI). Serum markers of inflammation included high-sensitivity C-reactive protein (hsCRP) and pro-inflammatory cytokines/receptors (IL-6, TNFR2). Higher levels of inflammation in patients with CD were variably associated with poorer neurobehavioral outcome, as indicated by parent and selfreport of cognitive and mood problems in daily life. TNFR2 emerged as the most robust predictor for executive problems, which were primarily of cognitive nature (see table). Effects remained after adjusting for pain, sleep, IQ, and prior steroid therapy. Correlations were modest but consistent with the literature. There was no sizable effect on laboratory cognitive measures. Results replicate earlier findings of the impact of inflammation on cognition and mood in children with CD. Higher levels of inflammation were associated with more reported problems in executive functions, including difficulties in controlling one's behavior, getting started on or completing tasks, working efficiently, as well as in attention and working memory. These functions are presumably mediated by prefrontal cortex, limbic system and potentially interconnecting white matter. While few effects were found on laboratory cognitive tests, patients and parents reported more cognitive problems in daily life associated with higher inflammatory markers. This discrepancy between test and questionnaire results in populations without frank neurological impairment is a known phenomenon in neuropsychological research, and one that is likely best addressed with the use of more sensitive neural measures such as neuroimaging. Clinically, these findings carry important implications for patient education, that underlying chronic inflammation, especially when untreated, can have far reaching developmental impact.

  • Open Access

    Inflammation and Steroid Therapy Is Associated With White Matter Microstructure Integrity in Pediatric Crohnʼs Disease

    by Christine Mrakotsky, Christopher Watson, Deborah Waber, Richard Grand, Michael Rivkin

    Pediatric Crohn's disease (CD) is marked by intestinal and systemic inflammation with high circulating concentrations of pro-inflammatory proteins (IL-6, TNF-α, CRP) during active disease. While anti-inflammatory treatments such as corticosteroids have for long been considered to affect cognitive and brain development, inflammation itself has the potential to disrupt the central nervous system, particularly the white matter. White matter abnormalities have been found at higher incidence in adults with CD as compared to healthy controls; however, no such data is available for pediatric CD. Loss of white matter integrity has been associated with functional impairment, particularly processing speed, memory, and emotion regulation. We previously found inflammation to be inversely correlated with cognition and mood in pediatric CD. We here provide a first report of the effects of inflammation vs. steroids on white matter microstructure integrity in pediatric CD. Structural and diffusion magnetic resonance imaging (MRI, DTI) was carried out in 30 children age 9-14 years (CD patients: n = 11, age-matched healthy controls: n = 19). Participants were scanned on a 3 Tesla Siemens Trio MRI system, with a 32-channel head coil. Diffusion-weighted imaging data were acquired using a single shot spin-echo echo planar imaging sequence. A total of 30 diffusion sensitization directions were acquired. Voxel sizes were 1.7 × 1.7 × 1.7 mm3. Average fractional anisotropy (FA), a measure reflecting white matter fiber density and myelination was computed for several fiber tracts across the brain. All CD patients were scanned during steroid treatment for an acute flare (prednisone dose: M = 30.7, SD = 9.6 mg/day). Serum markers of inflammation included hsCRP, IL-6, and TNFR2. Demographics, SES and general cognitive ability were comparable between groups. Inflammation was higher in CD patients than healthy controls. CD patients had lower FA than controls in several limbic (temporal) and subcortical fiber tracts including the left and right cingulum angular bundle, the right uncinate and temporal part of the superior longitudinal fasciculus (P<.05 to <.10). Regression models including all subjects accounting for inflammation levels and steroid dose revealed higher inflammation (hsCRP, IL6, TNFR2) but not steroid dose to be a significant predictor (P <.01 to <.05) for lower FA in the cingulum, particularly on the left. Conversely, higher steroid dose but not inflammation predicted lower FA in the right uncinate and temporal part of the superior longitudinal fasciculus (p <.05). Correlations between inflammation and FA adjusted for steroid yielded similar findings for the overall sample and for CD patients only (see table). Results of this first association between pediatric CD and brain development suggest differential impact of steroids and inflammatory markers on white matter microstructure. The inverse correlation between left cingulum integrity and circulating inflammation is of clinical interest as the cingulum is integral part of the limbic system, connecting prefrontal with medial temporal cortex and thus has been linked to emotion processing, memory and executive functions, - all previously associated with inflammation. Further neuroimaging and behavioral studies including CD patients off steroids are warranted to elucidate these initial findings.

  • Open Access

    Chronic Inflammation and Its Association With Neurobehavioral Functions in Pediatric Crohnʼs Disease

    by Christine Mrakotsky, Kristin Maletsky, Jonathan Girard, Deborah Waber, Athos Bousvaros, Richard Grand

    Pediatric Crohn's disease (CD) is associated with high circulating concentrations of pro-inflammatory cytokines (IL-6, TNF-α) and acute phase proteins (CRP). These proteins can cross the blood-brain-barrier. For example, IL-6 is expressed in the hippocampus, hypothalamus and cortex, TNF-α in microglia. Thus, excess cytokines have the potential to disrupt brain systems critical for memory, executive functions and mood. Children with CD therefore may be at particular risk for cognitive and emotional problems based on not only short and long-term medication regimens, but their underlying disease itself. Our earlier reports of behavioral impact of inflammation have been confounded by the fact that patients were concurrently treated with corticosteroids, which can cause similar behavioral and CNS side-effects. We here investigate the effects of inflammation on memory and executive functions independent of steroids. Behavioral and cytokine data from an ongoing NIH study were available on 61 children with CD age 8-16 years who have completed the study thus far. Patients were assessed at one time-point of a longitudinal design, when all were off steroids for at least 4-6 months. Standardized measures of memory, executive functions, IQ, mood, sleep, and pain severity were administered. Questionnaires included the Behavior Rating of Executive Functions (BRIEF), Child Behavior Checklist (CBCL), Youth Self Report (YSR), and Children's Depression Inventory (CDI). Serum markers of inflammation included high-sensitivity C-reactive protein (hsCRP) and pro-inflammatory cytokines/receptors (IL-6, TNFR2). Higher levels of inflammation in patients with CD were variably associated with poorer neurobehavioral outcome, as indicated by parent and selfreport of cognitive and mood problems in daily life. TNFR2 emerged as the most robust predictor for executive problems, which were primarily of cognitive nature (see table). Effects remained after adjusting for pain, sleep, IQ, and prior steroid therapy. Correlations were modest but consistent with the literature. There was no sizable effect on laboratory cognitive measures. Results replicate earlier findings of the impact of inflammation on cognition and mood in children with CD. Higher levels of inflammation were associated with more reported problems in executive functions, including difficulties in controlling one's behavior, getting started on or completing tasks, working efficiently, as well as in attention and working memory. These functions are presumably mediated by prefrontal cortex, limbic system and potentially interconnecting white matter. While few effects were found on laboratory cognitive tests, patients and parents reported more cognitive problems in daily life associated with higher inflammatory markers. This discrepancy between test and questionnaire results in populations without frank neurological impairment is a known phenomenon in neuropsychological research, and one that is likely best addressed with the use of more sensitive neural measures such as neuroimaging. Clinically, these findings carry important implications for patient education, that underlying chronic inflammation, especially when untreated, can have far reaching developmental impact.

  • Open Access

    Inflammation and Steroid Therapy Is Associated With White Matter Microstructure Integrity in Pediatric Crohnʼs Disease

    by Christine Mrakotsky, Christopher Watson, Deborah Waber, Richard Grand, Michael Rivkin

    Pediatric Crohn's disease (CD) is marked by intestinal and systemic inflammation with high circulating concentrations of pro-inflammatory proteins (IL-6, TNF-α, CRP) during active disease. While anti-inflammatory treatments such as corticosteroids have for long been considered to affect cognitive and brain development, inflammation itself has the potential to disrupt the central nervous system, particularly the white matter. White matter abnormalities have been found at higher incidence in adults with CD as compared to healthy controls; however, no such data is available for pediatric CD. Loss of white matter integrity has been associated with functional impairment, particularly processing speed, memory, and emotion regulation. We previously found inflammation to be inversely correlated with cognition and mood in pediatric CD. We here provide a first report of the effects of inflammation vs. steroids on white matter microstructure integrity in pediatric CD. Structural and diffusion magnetic resonance imaging (MRI, DTI) was carried out in 30 children age 9-14 years (CD patients: n = 11, age-matched healthy controls: n = 19). Participants were scanned on a 3 Tesla Siemens Trio MRI system, with a 32-channel head coil. Diffusion-weighted imaging data were acquired using a single shot spin-echo echo planar imaging sequence. A total of 30 diffusion sensitization directions were acquired. Voxel sizes were 1.7 × 1.7 × 1.7 mm3. Average fractional anisotropy (FA), a measure reflecting white matter fiber density and myelination was computed for several fiber tracts across the brain. All CD patients were scanned during steroid treatment for an acute flare (prednisone dose: M = 30.7, SD = 9.6 mg/day). Serum markers of inflammation included hsCRP, IL-6, and TNFR2. Demographics, SES and general cognitive ability were comparable between groups. Inflammation was higher in CD patients than healthy controls. CD patients had lower FA than controls in several limbic (temporal) and subcortical fiber tracts including the left and right cingulum angular bundle, the right uncinate and temporal part of the superior longitudinal fasciculus (P < .05 to < .10). Regression models including all subjects accounting for inflammation levels and steroid dose revealed higher inflammation (hsCRP, IL6, TNFR2) but not steroid dose to be a significant predictor (P < .01 to < .05) for lower FA in the cingulum, particularly on the left. Conversely, higher steroid dose but not inflammation predicted lower FA in the right uncinate and temporal part of the superior longitudinal fasciculus (p < .05). Correlations between inflammation and FA adjusted for steroid yielded similar findings for the overall sample and for CD patients only (see table). Results of this first association between pediatric CD and brain development suggest differential impact of steroids and inflammatory markers on white matter microstructure. The inverse correlation between left cingulum integrity and circulating inflammation is of clinical interest as the cingulum is integral part of the limbic system, connecting prefrontal with medial temporal cortex and thus has been linked to emotion processing, memory and executive functions, - all previously associated with inflammation. Further neuroimaging and behavioral studies including CD patients off steroids are warranted to elucidate these initial findings.